A detailed history of Guardian Wealth Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Guardian Wealth Management, Inc. holds 27,235 shares of ABT stock, worth $3.19 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
27,235
Previous 26,949 1.06%
Holding current value
$3.19 Million
Previous $2.8 Million 10.89%
% of portfolio
2.35%
Previous 2.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $28,620 - $33,785
286 Added 1.06%
27,235 $3.11 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $19,340 - $21,588
192 Added 0.72%
26,949 $2.8 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $876 - $967
-8 Reduced 0.03%
26,757 $3.04 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $15,693 - $19,209
174 Added 0.65%
26,765 $2.95 Million
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $3,439 - $4,126
36 Added 0.14%
26,591 $2.58 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $48,979 - $54,572
486 Added 1.86%
26,555 $2.9 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $25,667 - $30,212
265 Added 1.03%
26,069 $2.64 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $20,437 - $23,976
215 Added 0.84%
25,804 $2.83 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $26,705 - $30,920
276 Added 1.09%
25,589 $2.48 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $64,610 - $78,093
633 Added 2.56%
25,313 $2.75 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $27,592 - $33,647
242 Added 0.99%
24,680 $2.92 Million
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $2.82 Million - $3.46 Million
24,438 New
24,438 $3.44 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Guardian Wealth Management, Inc. Portfolio

Follow Guardian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.